Premarket Gainers as of 9:05 am (10/10/2018)

|By:, SA News Editor

NVCN +66% on FDA grants Breakthrough Device designation to Neovasc's Reducer.

NVLN +43%.

ESL +31% on being acquired by TransDigm.

IGC +18% on new battleground in cannabis market.

MBRX +14% on new data relating to its molecule WP1122 will be presented at the upcoming Society for Neuro-Oncology Annual Scientific Meeting.

TRVN +14% on positive analyst action.

NIO +13% on selecting Panasas ActiveStor storage technology to support the ongoing product design and development efforts of its high-performance, premium electric vehicles.

NBEV +10% on new battleground in cannabis market.

VLRX +14% as use of Valeritas’ V-Go Wearable Insulin Delivery Device 
significant clinical & economic benefits compared to conventional insulin delivery in patients with Type 2 diabetes.

AKRX +6% on receiving ANDA approval for Bimatoprost Ophthalmic Solution.

XXII +5%.

Subscribe for full text news in your inbox